131 Real World outcomes of advanced non-small cell lung cancer (NSCLC) patients according to time-of-day administration of combined chemo-immunotherapy. Guys, SE London Cancer Alliance Experience

Lung Cancer 2026

View at publisher
Authors: Alexandra Holdich, Negar Feizitalarposhti, Alfred Beard, Daniel Johnathan Hughes, Eleni M. Karapanagiotou, James F. Spicer, Alexandros Georgiou, Spyridon Gennatas
DOI: 10.1016/j.lungcan.2026.109080
Cited by: 0

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Lung Cancer Diagnosis and Treatment Lung Cancer Treatments and Mutations

Publication details

Journal / source
Lung Cancer
Volume
212
Pages
109080–109080
Publication date
1 February 2026
Language
EN